JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
3051
Autolus Therapeutics
AUTL
$567M
| $4.42M | ﹤0.01% |
851,544
-499,811
| -37% | -$3M |
|
3052
AtriCure
ATRC
$2.25B
| $4.4M | ﹤0.01% |
63,290
+30,576
| +93% | +$2.22M |
|
3053
PUT
Marvell Technology
MRVL
$198B
| $4.4M | ﹤0.01% |
+50,300
| New | +$3.76M |
|
3054
Skillsoft
SKIL
$74.9M
| $4.4M | ﹤0.01% |
24,029
-1,412
| -6% | -$325K |
|
3055
Astronics
ATRO
$4.61B
| $4.39M | ﹤0.01% |
439,532
-259,427
| -37% | -$2.72M |
|
|
GGMC
3056
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
| $4.38M | ﹤0.01% |
+450,000
| New | +$4.38M |
|
3057
PUT
CSX Corp
CSX
$93.1B
| $4.38M | ﹤0.01% |
116,400
| – | – |
|
3058
Dycom Industries
DY
$12.5B
| $4.37M | ﹤0.01% |
46,562
+1,045
| +2% | +$88.4K |
|
|
ASZ
3059
DELISTED
Austerlitz Acquisition Corporation II
ASZ
| $4.36M | ﹤0.01% |
+449,000
| New | +$4.39M |
|
3060
CALL
Southern Company
SO
$107B
| $4.36M | ﹤0.01% |
63,600
-102,400
| -62% | -$6.53M |
|
3061
CALL
AMC Entertainment Holdings
AMC
$2.23B
| $4.36M | ﹤0.01% |
16,020
-2,000
| -11% | -$704K |
|
3062
Domo
DOMO
$185M
| $4.35M | ﹤0.01% |
87,697
+47,505
| +118% | +$3.49M |
|
3063
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.11B
| $4.35M | ﹤0.01% |
131,847
+12,378
| +10% | +$407K |
|
3064
Grove Collaborative
GROV
$44.4M
| $4.34M | ﹤0.01% |
88,000
+17,400
| +25% | +$854K |
|
|
TCRR
3065
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $4.34M | ﹤0.01% |
930,835
-99,525
| -10% | -$622K |
|
|
INFN
3066
DELISTED
Infinera Corporation Common Stock
INFN
| $4.34M | ﹤0.01% |
452,420
+336,289
| +290% | +$2.85M |
|
3067
iShares MSCI Japan Small-Cap ETF
SCJ
$265M
| $4.34M | ﹤0.01% |
57,577
+14,247
| +33% | +$1.12M |
|
|
PAQC
3068
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
| $4.33M | ﹤0.01% |
440,000
| – | – |
|
|
AYX
3069
DELISTED
Alteryx Inc
AYX
| $4.33M | ﹤0.01% |
71,504
-71,296
| -50% | -$4.92M |
|
3070
PUT
Amgen
AMGN
$224B
| $4.32M | ﹤0.01% |
19,200
-44,400
| -70% | -$9.37M |
|
|
UHT
3071
Universal Health Realty Income Trust
UHT
$575M
| $4.32M | ﹤0.01% |
72,594
+4,273
| +6% | +$249K |
|
|
JWN
3072
DELISTED
Nordstrom
JWN
| $4.31M | ﹤0.01% |
190,641
-150,626
| -44% | -$3.99M |
|
3073
AudioCodes
AUDC
$256M
| $4.3M | ﹤0.01% |
123,706
+40,369
| +48% | +$1.41M |
|
3074
Cartesian Therapeutics
RNAC
$264M
| $4.3M | ﹤0.01% |
43,924
-17,859
| -29% | -$1.92M |
|
3075
WesBanco
WSBC
$4.09B
| $4.29M | ﹤0.01% |
122,609
+26,295
| +27% | +$925K |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.